DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Dreyer L, Cordtz RL, Hansen IMJ. et al.
Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study.
Ann Rheum Dis 2018;
77: 510-514
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.